Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient.

Literature DB >> 27649838

Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient.

Takashi Arai¹, Kazutoshi Harada¹, Yoshihiko Usui², Ryokichi Irisawa¹, Ryoji Tsuboi¹.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2016 PMID： 27649838 DOI： 10.1111/1346-8138.13612

Source DB: PubMed Journal: J Dermatol ISSN： 0385-2407 Impact factor: 4.005

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

1. Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.

Authors: Daniel Russell Richardson; Brian Ellis; Inderjit Mehmi; Monique Leys
Journal: Int J Ophthalmol Date: 2017-07-18 Impact factor: 1.779

Review 2. Toxicity of tumor immune checkpoint inhibitors-more attention should be paid.

Authors: Yu Liu; Hao Wang; Juan Deng; Chenglong Sun; Yayi He; Caicun Zhou
Journal: Transl Lung Cancer Res Date: 2019-12

3. Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition.

Authors: Michel M Sun; Ralph D Levinson; Artur Filipowicz; Stephen Anesi; Henry J Kaplan; Wei Wang; Debra A Goldstein; Sapna Gangaputra; Robert T Swan; H Nida Sen; Lynn K Gordon
Journal: Ocul Immunol Inflamm Date: 2019-03-01 Impact factor: 3.070

Review 4. Melanoma and Immune Checkpoint Inhibitors.

Authors: Masutaka Furue; Takamichi Ito; Naoko Wada; Maiko Wada; Takafumi Kadono; Hiroshi Uchi
Journal: Curr Oncol Rep Date: 2018-03-23 Impact factor: 5.075

Review 5. Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management.

Authors: Yu-Wen Zhou; Qian Xu; Yan Wang; Ruo-Lan Xia; Ji-Yan Liu; Xue-Lei Ma
Journal: Int J Ophthalmol Date: 2022-04-18 Impact factor: 1.779

Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient.

1. Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.

Review 2. Toxicity of tumor immune checkpoint inhibitors-more attention should be paid.

3. Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition.

Review 4. Melanoma and Immune Checkpoint Inhibitors.

Review 5. Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management.

Review 6. Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer.

7. Bilateral Uveitis and Keratitis Following Nivolumab Treatment for Metastatic Melanoma.

8. Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma.

Review 9. Overview of Ocular Side Effects of Selinexor.

10. Bilateral uveitis and macular edema induced by Nivolumab: a case report.